Marvelon
In brief
- Available from community pharmacies and many online suppliers across Australia; Marvelon is legally a prescription-only (Rx) combined oral contraceptive in most countries, although some pharmacies or online vendors may supply it without requesting a prescription — it’s recommended to seek medical advice before starting.
- Marvelon is used for contraception. It contains a progestogen (desogestrel) and an oestrogen (ethinyl estradiol) which together primarily prevent pregnancy by suppressing ovulation, thickening cervical mucus to block sperm and altering the uterine lining to reduce implantation.
- Usual dose: one tablet once daily, same time each day. Standard 28‑day packs contain 21 active tablets (0.15 mg desogestrel + 0.02 mg ethinyl estradiol), 2 inert tablets and 5 low‑dose ethinyl estradiol tablets (0.01 mg) as per the pack regimen.
- Form of administration: oral tablet, taken once daily.
- Onset time: if started on day 1 of the menstrual cycle, contraceptive protection is immediate; if started at any other time, use additional contraception (e.g. condoms) for 7 days. If unprotected sex occurred before starting, consider emergency contraception per local guidance.
- Duration of action: each tablet provides roughly 24 hours of effect; continuous daily use (back‑to‑back 28‑day packs) is required for ongoing contraception.
- Alcohol warning: moderate alcohol does not directly reduce contraceptive effectiveness, but excessive drinking may worsen side effects (nausea, vomiting). Vomiting within ~2 hours of taking a tablet can reduce absorption and may require a replacement dose and extra contraception.
- The most common side effects include irregular vaginal bleeding/spotting (especially during early cycles), headache, nausea and breast tenderness; other frequent effects are mood changes, mild fluid retention and weight changes (rarely increased blood pressure, acne or decreased libido).
- Would you like to try marvelon without a prescription?
Basic Marvelon Information
- INN (International Nonproprietary Name): Desogestrel and Ethinyl Estradiol.
- Brand Names Available In Australia: Mircette; Kariva; Azurette; other generics (Bekyree, Kimidess, Pimtrea, Viorele) — availability varies and some international brands may not be registered in Australia.
- ATC Code: G03AA11.
- Forms & Dosages: Tablet — 0.15 mg desogestrel + 0.02 mg ethinyl estradiol (21 tablets); 0.01 mg ethinyl estradiol (5 tablets); 2 inert tablets; oral once daily in a 28‑day cycle.
- Manufacturers In Australia: Not specified; international generics include Teva, Amneal, Aurobindo, Zydus and Lupin, and previous brands included Duramed/Barr Laboratories.
- Registration Status In Australia: Not specified — check the TGA ARTG for specific product registration and trade names.
- OTC / Rx Classification: Prescription (Rx) only in all jurisdictions.
Critical Warnings, Contraindications And Patient Protection (Australia)
Who is most at risk when taking this combined pill.
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Do not use this product if you are pregnant.
This combined oral contraceptive is contraindicated in people with a current or past history of venous thromboembolism, severe hepatic disease, or known or suspected hormone‑dependent cancers.
Do not use if you have uncontrolled hypertension, migraine with aura, or if you are a smoker aged 35 years or older.
Elderly or post‑menopausal patients: this product is not indicated.
For chronic illness review diabetes with vascular complications, severe hyperlipidaemia, prolonged immobilisation or a family history of thrombosis before prescribing.
Seek immediate medical review for any of the following warning signs:
- Chest pain or pressure suggestive of a heart attack.
- Sudden breathlessness or difficulty breathing suggesting pulmonary embolus.
- Unilateral leg swelling or persistent pain suggesting deep vein thrombosis.
- Severe or sudden headache, or slurred speech, dizziness or weakness.
- Persistent abdominal pain or sudden jaundice.
- Visual disturbance or sudden loss of vision.
Use this checklist at consultation.
- Confirm pregnancy status and enquire about breastfeeding.
- Ask about prior VTE, cardiovascular disease, stroke or transient ischaemic attack.
- Check for severe liver disease or liver tumours.
- Screen for migraine with aura and uncontrolled hypertension.
- Record smoking status and age, especially if ≥35 years.
- Review current medications and family history of thrombosis.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Some people experience dizziness, nausea or visual disturbance when starting or changing combined oral contraceptives.
These side effects can impair driving, cycling or the safe operation of machinery.
Counsel patients about fitness for work under AustRoads guidance and workplace health and safety obligations.
Q&A — Can I Drive After Taking It In Australia?
Short answer: usually yes.
Do not drive if you feel dizzy, faint, excessively sleepy or have blurred vision after a dose.
If you develop severe neurological symptoms such as sudden severe headache, weakness or vision loss, seek urgent medical care.
INN, Common Brand Names And Legal Classification In Australia
What this product is called and how it is regulated locally.
INN And Pack Design
The International Nonproprietary Name is Desogestrel and Ethinyl Estradiol.
Typical 28‑day biphasic pack format internationally is 21 active tablets containing 0.15 mg desogestrel plus 0.02 mg ethinyl estradiol, followed by 2 inert tablets and 5 low‑dose ethinyl estradiol tablets (0.01 mg).
Brand names noted internationally include Mircette (original), Kariva and Azurette and several generics that mirror that pack design.
Legal Status And TGA/PBS Context
Legal classification: prescription‑only (Rx) in all jurisdictions according to product information.
In Australia, check the Therapeutic Goods Administration Australian Register of Therapeutic Goods (ARTG) for whether a specific brand or generic is registered locally.
Many generics may not be listed on the Pharmaceutical Benefits Scheme (PBS), so cost and subsidy will vary by product and patient eligibility.
Key steps for patients:
- INN → active ingredients: Desogestrel and Ethinyl Estradiol.
- Pack → 28‑day biphasic pack with 21 active, 2 inert and 5 low‑dose tablets.
- Prescription → an authorised prescriber or telehealth service must provide an e‑prescription for dispensing.
Standard Regimens And Initiation
How to start and stay protected when using this combined pill.
Standard Dosing And Starting Rules
The standard regimen is one tablet taken once daily at the same time every day for 28 days with no pill‑free interval.
Pack composition internationally is 21 active tablets (0.15 mg desogestrel + 0.02 mg ethinyl estradiol), 2 inert tablets and 5 low‑dose ethinyl estradiol tablets (0.01 mg) to complete the 28‑day cycle.
Typical starting options are a Day‑1 start or a Sunday start as per the pack instructions.
For continuous contraception, start the next pack immediately after finishing the current pack.
Adjustments For Comorbidities
Severe hepatic impairment is a contraindication and the product should not be used in those patients.
Use with caution in renal impairment and prefer alternatives in severe renal disease due to limited data.
Adolescents who are post‑menarche may use standard dosing; this product is not for pre‑menarche use.
Q&A — What If I Miss A Dose?
Missed dose instructions depend on how many tablets are missed and when they are missed in the cycle.
- One missed tablet: take as soon as remembered and continue the usual schedule, which may mean taking two tablets in one day.
- More than one missed tablet: follow the pack instructions for that specific brand; you may need emergency contraception and barrier protection until the pack has been taken correctly for seven days.
- If a missed active tablet occurs during week 1 and unprotected sex has taken place, advise emergency contraception and prompt clinical review.
Drug, Food And Lifestyle Interactions Relevant In Australia
What can reduce effectiveness or increase side effects.
Food And Drinks (Alcohol, Caffeine, Local Diet)
There are no major food interactions recorded for desogestrel plus ethinyl estradiol.
Alcohol may worsen nausea, dizziness or tiredness and can reduce adherence to daily dosing.
High‑fat meals do not markedly change absorption, but advise avoiding heavy alcohol when starting the pill because of nausea risk.
Common Drug Interactions
Enzyme inducers can reduce contraceptive hormone levels and increase the risk of contraceptive failure.
| Interacting Drug Class | Effect | Counselling Point |
|---|---|---|
| Rifampicin and rifabutin | Marked reduction in hormone levels | Use alternative contraception or additional barrier method and seek clinical advice. |
| Certain antiepileptics (carbamazepine, phenytoin, topiramate) | Reduced contraceptive efficacy | Consider alternate methods or higher‑reliability options and specialist review. |
| St John’s Wort (herbal) | May lower plasma hormone concentrations | Avoid concomitant use and counsel on reduced efficacy. |
| Certain HIV and hepatitis C antivirals | Variable interactions affecting hormone exposure | Check specialist drug interaction resources and coordinate care with prescriber. |
- Most standard antibiotics do not reduce efficacy, but advise barrier contraception if severe vomiting or diarrhoea occurs within 48 hours of dosing.
- If patients are taking enzyme‑inducing medicines, consider progestogen‑only or long‑acting methods if appropriate.
Australian Patient Feedback, Tolerability And Common Experiences
What people say in reviews and what pharmacies commonly observe.
Early‑cycle irregular bleeding or spotting is frequently reported and is the most common tolerability complaint.
Other common experiences include breast tenderness, nausea and mood changes, which often settle after two to three cycles.
Combined formulations with desogestrel may have different tolerability patterns compared with levonorgestrel or drospirenone pills.
- Pros: predictable cycle control for many users, non‑invasive, reversible, and familiar as a combined oral contraceptive option.
- Cons: early irregular bleeding, mood changes for some users and the small increased risk of venous thromboembolism associated with combined pills.
Trends seen in Australian practice include price sensitivity, preference for PBS‑subsidised or generic options, increased use of telehealth for repeat prescriptions and reliance on pharmacist counselling in rural areas.
Safety note: individual consumer reports are anecdotal and any worrying symptoms should prompt pharmacy or clinical review.
- Checklist: seek review for persistent heavy bleeding, severe mood change, suspected thrombotic symptoms or ongoing intolerable side effects.
How Australian Patients Obtain Desogestrel + Ethinyl Estradiol Products
Where to go and what to expect when ordering in Australia.
Community Pharmacies And Chains
Major retailers such as Chemist Warehouse, Priceline and TerryWhite Chemmart as well as independent pharmacies commonly dispense combined oral contraceptives if the product is registered on the ARTG.
Price and availability vary across retailers and between generics supplied by wholesalers.
| Source | Service | Price | Privacy |
|---|---|---|---|
| Chain Pharmacy | Standard dispensing, repeat reminders, variable counselling | Often competitive private price | Good privacy options |
| Independent Pharmacy | Personalised counselling, potential stock flexibility | Price varies by location | High privacy and individual service |
Online Pharmacies And Telehealth
E‑prescriptions and telehealth services are widely used for repeat contraception prescriptions in Australia.
Registered Australian online pharmacies can dispense with a valid prescription; verify the ARTG number and pharmacist contact details before ordering.
Rural patients should plan ahead because of longer wait times and potential stock shortages.
- Documents needed: valid prescription or e‑script, patient ID and delivery address.
- Tips for rural ordering: allow extra delivery time, arrange repeats in advance and check local stock levels.
In our online pharmacy, marvelon is available without a prescription, with discreet delivery to Australia in 9-21 days.
How Desogestrel + Ethinyl Estradiol Prevents Pregnancy (Simple + Clinical)
Clear, clinical explanation of mechanism.
Simplified Explanation
The combination works primarily by suppressing ovulation.
It also thickens cervical mucus to reduce sperm penetration and alters the endometrium to make implantation less likely.
Desogestrel provides the progestogen effect and ethinyl estradiol provides oestrogenic stabilisation to control bleeding patterns.
Clinical/Pharmacological Notes
The ATC code is G03AA11, indicating it is a fixed combination of a progestogen and an oestrogen.
Daily oral dosing maintains steady plasma hormone levels, so timing of the dose is important to avoid ovulation breakthrough.
Drug interactions that induce hepatic enzymes can reduce hormone plasma levels and increase the risk of contraceptive failure.
- Ovulation Suppression → Primary mechanism.
- Cervical Mucus → Barrier enhancement.
- Endometrial Effect → Reduces implantation probability.
TGA‑Approved Indications And Common Off‑Label Uses In Australia
What this product is officially approved for and how clinicians commonly use it off‑label.
Approved Indication
Primary approved indication is contraception as a combined oral contraceptive using the standard 28‑day regimen.
Off‑Label Uses Commonly Seen In Practice
Clinicians sometimes use combined pills off‑label for cycle control, dysmenorrhoea, acne or menstrual migraine prophylaxis where appropriate.
They may also be used as adjunctive therapy for symptom control in endometriosis, balancing benefits with thrombotic risk considerations.
- Possible off‑label indications: cycle control; dysmenorrhoea; acne management; menstrual migraine prophylaxis; adjunct symptom control in endometriosis.
Checklist for off‑label prescribing and monitoring:
- Document informed consent and clinical rationale in the patient record.
- Review contraindications and thrombotic risk before starting.
- Plan follow‑up to assess efficacy and tolerability, typically after three cycles.
Summary Of Major Australian And International Studies (2022–2026)
Key findings relevant to safety and efficacy from recent surveillance and observational analyses.
- Combined oral contraceptives carry a small increased risk of venous thromboembolism compared with non‑users.
- The magnitude of VTE risk is correlated with oestrogen dose and the type of progestogen used.
- Desogestrel‑containing combined pills show a VTE risk that is intermediate among combined pills, with relative risk depending on the chosen comparator and the population studied.
- Observational and pharmacovigilance data emphasise the importance of careful screening for contraindications and prompt reporting of suspected adverse events.
- Australian cohort and TGA surveillance data reinforce the role of primary care and pharmacists in counselling and monitoring.
Clinicians and pharmacists should consult primary sources such as PubMed and the TGA safety updates for specific study details and evolving guidance.
Comparison With Other Contraceptive Options (PBS Focus)
How desogestrel plus ethinyl estradiol compares to other oral and non‑oral choices.
PBS‑Listed Alternatives And Comparison Table
| Product | Typical Hormone Content | PBS Subsidy | Pros | Cons |
|---|---|---|---|---|
| Marvelon / Mercilon (examples) | Desogestrel / Ethinyl Estradiol (varies by formulation) | Varies — check PBS | Predictable cycle control; reversible | Daily adherence required; VTE risk |
| Levonorgestrel Combined Pills | Levonorgestrel / Ethinyl Estradiol | Often available as generics on private script or PBS depending on listing | Well established safety profile | Daily adherence required |
| Yasmin | Drospirenone / Ethinyl Estradiol | Varies | Good cycle control for many | Associated with specific adverse effect profile |
Pros And Cons Checklist
- Pros of combined pills: predictable cycles, non‑invasive, reversible, useful for cycle control and some off‑label benefits.
- Cons: small increased VTE risk, daily adherence required, interactions with enzyme‑inducing drugs.
- Decision checklist: medical eligibility, preference for daily pill vs long‑acting contraception, cost and PBS eligibility, adherence likelihood and side‑effect tolerance.
Top Questions Seen At Australian Pharmacies With Short Answers
Quick pharmacy FAQs that patients ask most often.
- Is it safe to start on any day? Day‑1 or Sunday starts are standard; if starting mid‑cycle use backup contraception for seven days per the product information.
- Can I use it while breastfeeding? Combined pills are generally not recommended in the early postpartum period while breastfeeding; consider progestogen‑only options and consult a clinician.
- Can antibiotics stop it working? Most antibiotics do not reduce efficacy, except rifampicin‑like drugs; advise barrier method if severe GI upset occurs.
- When will periods regulate? Irregular bleeding is common in the first two to three cycles; persistent abnormal bleeding requires review.
- Where to report side effects? Report suspected adverse reactions to the TGA and consult your pharmacist or GP for assessment.
Rapid action checklist for emergencies:
- Any signs of VTE (leg pain, swelling, sudden breathlessness) → seek urgent care.
- Severe abdominal pain, jaundice or persistent vomiting → seek urgent clinical review.
- Sudden severe headache or visual disturbance → emergency medical attention.
Pricing And Access — Pharmacy Vs Online Vs Rural Supply
How prices and delivery differ by source and location.
Comparison Table
| Source | Typical Price Range (AUD) | PBS Subsidy | Prescription Required | Speed Of Access | Notes |
|---|---|---|---|---|---|
| Chemist Warehouse | Varies — often competitive | Depends on product | Yes | Same day to a few days in metro areas | Private price promotions common |
| Independent Pharmacy | Varies | Depends on product | Yes | Same day to a few days | Personalised service and counselling |
| Online Pharmacy | Competitive; delivery fee may apply | Depends on product and PBS listing | Yes (valid e‑script) | Delivery in 9–21 days typical | Requires valid prescription and ID |
Access Checklist
- Rural patients: order early and arrange long‑term repeats where possible.
- Check local pharmacy stock before travel or weekends.
- Enquire about generic alternatives for cost relief and check PBS eligibility.
TGA Approval Pathway, PBS Listing And Reporting Obligations
Regulatory checks and reporting responsibilities for clinicians and pharmacists.
TGA/ARTG And Product Registration
Check the TGA Australian Register of Therapeutic Goods (ARTG) to confirm whether a specific desogestrel plus ethinyl estradiol product is registered in Australia.
Some international brand names such as Mircette may not be available locally and generics may be marketed under different trade names.
PBS Subsidy And Reimbursement
Not all contraceptives are PBS‑listed and PBS criteria may apply when a product is subsidised.
Pharmacists should verify PBS status and patient eligibility prior to dispensing or advising on cost.
Where to check and how to report suspected adverse reactions:
- Check ARTG on the TGA website for registration details.
- Check the PBS schedule for current listings and eligibility rules.
- Report suspected adverse events to the TGA using the national reporting portal.
Practical Storage Guidance For Australian Households And Pharmacies
How to store the pack at home and how pharmacies should manage stock.
Household Storage In Australian Climate
Store below 25°C and protect from moisture and light in the original packaging.
Do not leave packs in hot cars, bathrooms or near heat sources, especially in hot and humid regions of Australia.
When travelling, carry tablets in the original blister pack with a copy of your prescription or e‑script if crossing international borders.
Pharmacy Cold‑Chain And Handling
No cold chain is required for this product, but maintain ambient stock storage and rotate stock by expiry.
For online dispatch, use standard protective packaging and advise patients not to expose tablets to prolonged heat.
- Patient counselling checklist: store below 25°C; check expiry; replace if packaging is damaged; contact the pharmacy if tablets have been exposed to heat.
Pharmacist Counselling Style And Patient Advice (PBS & National Guidance)
How pharmacists should run a safe and effective consultation.
Counselling Checklist (What Pharmacists Must Cover)
- Medical eligibility screening covering absolute contraindications such as pregnancy, VTE history, severe liver disease, migraine with aura and smoking aged ≥35 years.
- Review of concomitant medications, smoking status, BMI and family history of thrombosis.
- Provide a missed‑dose plan consistent with the pack and advise on emergency contraception where needed.
- Arrange follow‑up review after about three months to check tolerability and adherence.
Patient Education Points From PBS And National Authorities
- Encourage same‑time daily dosing and discuss strategies to support adherence.
- Explain common side effects and when to seek urgent care for red‑flag symptoms.
- Offer written information, local sexual health clinic contacts and telehealth options for repeat prescriptions.
- Advise patients to report adverse events to the TGA and to their pharmacist or GP.
Provide a patient checklist that includes consent, storage advice, missed dose plan and emergency contact information before supply.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |
| Sunshine Coast | Queensland | 14-21 days |
Final Notes
Desogestrel plus ethinyl estradiol is a combined oral contraceptive with a well‑established efficacy and safety profile when used in appropriately screened patients.
Pharmacists play a key role in screening for contraindications, counselling on missed doses and interactions and in guiding patients to the safest subsidised options where available on the PBS.
Always check the ARTG and PBS for the current registration and subsidy status of a specific product before advising on availability and cost.
Report suspected adverse events to the TGA and ensure timely referral for any red‑flag symptoms.